Please Wait.....
Report
Italy Point-of-Care Glucose Testing Market By Product Type (Lancing Devices and Strips, Blood-Glucose Meter), By Application (Type-1 Diabetes, Type-2 Diabetes), By End User (Hospitals and Clinics, Home Care Settings, Others): Opportunity Analysis and Industry Forecast, 2023-2032
Market Report I 2023-06-01 I 79 Pages I Allied Market Research
The Italy point-of-care glucose testing market has been witnessing significant growth during the forecast period, owing to increase in innovation and rise in technological advancement. Moreover, the continuous pursuit for accurate and user-friendly glucose testing tools is a key factor driving the market growth.However, challenges regarding reimbursements and the inherent intricacies of diabetes management are the key factors restraining the growth of the Italy point-of-care glucose testing market.The Italy point-of-care glucose testing market is segmented into product type, application, and end user. On the basis of product type, the market is classified into lancing devices & strips and blood-glucose meter. As per application, it is bifurcated into type-1 diabetes and type-2 diabetes. By end user, it is categorized into hospitals & clinics, home care settings, and others.On the contrary, surge in innovation is one of the key trends driving the market growth. Furthermore, the convergence of technology and healthcare promises to make glucose testing seamless, accurate, and patient-centric. In addition, companies are collaborating with healthcare providers and insurance companies to gain a competitive edge in the market.
Moreover, companies are investing in R&D activities and product development to gain a competitive edge in the Italy point-of-care glucose testing market.Furthermore, manufacturers are actively seeking ways to minimize the environmental footprint of their products, incorporating sustainable packaging and implementing strategies to reduce waste in glucose testing process. In addition, key players in the market are collaborating to enhance their product portfolios and expand their market presence. This collaborative approach stimulates competition, fosters innovation, and promotes product diversification, ultimately providing end users with a broader selection of options.The Porter's five forces analysis assesses the competitive strength of the players in the point-of-care glucose testing market. These five forces include the threat of new entrants, the bargaining power of suppliers, the bargaining power of buyers, the threat of substitutes, and competitive rivalry.
The threat of new entrants is high. The bargaining power of suppliers is moderate. The bargaining power of buyers is high. The threat of substitutes is moderate. The competitive rivalry is high.A SWOT analysis of the Italy point-of-care glucose testing market includes strengths, weaknesses, opportunities, and threats. Strengths include industry's commitment to innovation, rise in prevalence of diabetes, and the market's adaptability.Weaknesses include the regulatory challenges that restrain the market growth and the inherent complexities of managing diabetes. Moreover, market players are often required to make substantial investments in R&D, which is a financial strain.Opportunities include the potential for technological breakthroughs and collaborations with healthcare providers. The market harnesses the power of data analytics and telemedicine to create integrated and efficient solutions for diabetes management.Threats include regulatory changes and reimbursement uncertainties.
Key players operating in the Italy point-of-care glucose testing market include Roche Diagnostics, Abbott Laboratories, Becton, Dickinson and Co., Bayer AG, Nova Biomedical Corporation, Beckman Coulter, Inc., EKF Diagnostics, HDI Diagnostics, Menarini Diagnostics and Arkray, Inc.
Key Benefits For Stakeholders
Enable informed decision-making process and offer market analysis based on current market situation and estimated future trends.
Analyze the key strategies adopted by major market players in Italy point-of-care glucose testing market.
Assess and rank the top factors that are expected to affect the growth of Italy point-of-care glucose testing market.
Top Player positioning provides a clear understanding of the present position of market players.
Detailed analysis of the Italy point-of-care glucose testing market segmentation assists to determine the prevailing market opportunities.
Identify key investment pockets for various offerings in the market.
Additional benefits you will get with this purchase are:
- Quarterly Update and* (only available with a corporate license, on listed price)
- 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
- Free Upcoming Version on the Purchase of Five and Enterprise User License.
- 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
- 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
- Free data Pack on the Five and Enterprise User License. (Excel version of the report)
- Free Updated report if the report is 6-12 months old or older.
- 24-hour priority response*
- Free Industry updates and white papers.
Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
- Product Benchmarking / Product specification and applications
- Upcoming/New Entrant by Regions
- New Product Development/ Product Matrix of Key Players
- Regulatory Guidelines
- Additional company profiles with specific to client's interest
- Additional country or region analysis- market size and forecast
- Expanded list for Company Profiles
- Historic market data
- SWOT Analysis
Key Market Segments
By Product Type
- Lancing Devices and Strips
- Blood-Glucose Meter
- Type
- Lifescan OneTouch Ultra and Lifescan OneTouch Verio
- Accu-Chek Aviva Plus and Accuchek
- Freestyle Lite and Freestyle Precission Neo
- Contour Next
- Others
By Application
- Type-1 Diabetes
- Type-2 Diabetes
By End User
- Hospitals and Clinics
- Home Care Settings
- Others
- Key Market Players
- Roche Diagnostics
- Abbott Laboratories
- Becton, Dickinson and Co.
- Bayer AG
- Nova Biomedical Corporation
- Beckman Coulter, Inc.
- EKF Diagnostics
- HDI Diagnostics
- Menarini Diagnostics
- Arkray, Inc.
CHAPTER 1: INTRODUCTION
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits to the Stakeholders
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Impacting Factors
3.2.2. Top Investment Pockets
3.3. Porter's Five Forces Analysis
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
3.5. COVID-19 Impact Analysis on the market
CHAPTER 4: ITALY POINT-OF-CARE GLUCOSE TESTING MARKET, BY PRODUCT TYPE
4.1. Overview
4.1.1. Market Size and Forecast, By Product Type
4.2. Lancing Devices and Strips
4.3. Blood-Glucose Meter
CHAPTER 5: ITALY POINT-OF-CARE GLUCOSE TESTING MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market Size and Forecast, By Application
5.2. Type-1 Diabetes
5.3. Type-2 Diabetes
CHAPTER 6: ITALY POINT-OF-CARE GLUCOSE TESTING MARKET, BY END USER
6.1. Overview
6.1.1. Market Size and Forecast, By End User
6.2. Hospitals and Clinics
6.3. Home Care Settings
6.4. Others
CHAPTER 7: COMPETITIVE LANDSCAPE
7.1. Introduction
7.2. Top winning strategies
7.3. Product Mapping of Top 10 Player
7.4. Competitive Dashboard
7.5. Competitive Heatmap
7.6. Top player positioning, 2022
CHAPTER 8: COMPANY PROFILES
8.1. Roche Diagnostics
8.1.1. Company overview
8.1.2. Key Executives
8.1.3. Company snapshot
8.1.4. Operating business segments
8.1.5. Product portfolio
8.1.6. Business performance
8.1.7. Key strategic moves and developments
8.2. Abbott Laboratories
8.2.1. Company overview
8.2.2. Key Executives
8.2.3. Company snapshot
8.2.4. Operating business segments
8.2.5. Product portfolio
8.2.6. Business performance
8.2.7. Key strategic moves and developments
8.3. Becton, Dickinson and Co.
8.3.1. Company overview
8.3.2. Key Executives
8.3.3. Company snapshot
8.3.4. Operating business segments
8.3.5. Product portfolio
8.3.6. Business performance
8.3.7. Key strategic moves and developments
8.4. Bayer AG
8.4.1. Company overview
8.4.2. Key Executives
8.4.3. Company snapshot
8.4.4. Operating business segments
8.4.5. Product portfolio
8.4.6. Business performance
8.4.7. Key strategic moves and developments
8.5. Nova Biomedical Corporation
8.5.1. Company overview
8.5.2. Key Executives
8.5.3. Company snapshot
8.5.4. Operating business segments
8.5.5. Product portfolio
8.5.6. Business performance
8.5.7. Key strategic moves and developments
8.6. Beckman Coulter, Inc.
8.6.1. Company overview
8.6.2. Key Executives
8.6.3. Company snapshot
8.6.4. Operating business segments
8.6.5. Product portfolio
8.6.6. Business performance
8.6.7. Key strategic moves and developments
8.7. EKF Diagnostics
8.7.1. Company overview
8.7.2. Key Executives
8.7.3. Company snapshot
8.7.4. Operating business segments
8.7.5. Product portfolio
8.7.6. Business performance
8.7.7. Key strategic moves and developments
8.8. HDI Diagnostics
8.8.1. Company overview
8.8.2. Key Executives
8.8.3. Company snapshot
8.8.4. Operating business segments
8.8.5. Product portfolio
8.8.6. Business performance
8.8.7. Key strategic moves and developments
8.9. Menarini Diagnostics
8.9.1. Company overview
8.9.2. Key Executives
8.9.3. Company snapshot
8.9.4. Operating business segments
8.9.5. Product portfolio
8.9.6. Business performance
8.9.7. Key strategic moves and developments
8.10. Arkray, Inc.
8.10.1. Company overview
8.10.2. Key Executives
8.10.3. Company snapshot
8.10.4. Operating business segments
8.10.5. Product portfolio
8.10.6. Business performance
8.10.7. Key strategic moves and developments
LIST OF TABLES
TABLE 01. ITALY POINT-OF-CARE GLUCOSE TESTING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 02. ITALY POINT-OF-CARE GLUCOSE TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 03. ITALY POINT-OF-CARE GLUCOSE TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 04. ROCHE DIAGNOSTICS: KEY EXECUTIVES
TABLE 05. ROCHE DIAGNOSTICS: COMPANY SNAPSHOT
TABLE 06. ROCHE DIAGNOSTICS: OPERATING SEGMENTS
TABLE 07. ROCHE DIAGNOSTICS: PRODUCT PORTFOLIO
TABLE 08. ROCHE DIAGNOSTICS: KEY STRATERGIES
TABLE 09. ABBOTT LABORATORIES: KEY EXECUTIVES
TABLE 10. ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 11. ABBOTT LABORATORIES: OPERATING SEGMENTS
TABLE 12. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
TABLE 13. ABBOTT LABORATORIES: KEY STRATERGIES
TABLE 14. BECTON, DICKINSON AND CO.: KEY EXECUTIVES
TABLE 15. BECTON, DICKINSON AND CO.: COMPANY SNAPSHOT
TABLE 16. BECTON, DICKINSON AND CO.: OPERATING SEGMENTS
TABLE 17. BECTON, DICKINSON AND CO.: PRODUCT PORTFOLIO
TABLE 18. BECTON, DICKINSON AND CO.: KEY STRATERGIES
TABLE 19. BAYER AG: KEY EXECUTIVES
TABLE 20. BAYER AG: COMPANY SNAPSHOT
TABLE 21. BAYER AG: OPERATING SEGMENTS
TABLE 22. BAYER AG: PRODUCT PORTFOLIO
TABLE 23. BAYER AG: KEY STRATERGIES
TABLE 24. NOVA BIOMEDICAL CORPORATION: KEY EXECUTIVES
TABLE 25. NOVA BIOMEDICAL CORPORATION: COMPANY SNAPSHOT
TABLE 26. NOVA BIOMEDICAL CORPORATION: OPERATING SEGMENTS
TABLE 27. NOVA BIOMEDICAL CORPORATION: PRODUCT PORTFOLIO
TABLE 28. NOVA BIOMEDICAL CORPORATION: KEY STRATERGIES
TABLE 29. BECKMAN COULTER, INC.: KEY EXECUTIVES
TABLE 30. BECKMAN COULTER, INC.: COMPANY SNAPSHOT
TABLE 31. BECKMAN COULTER, INC.: OPERATING SEGMENTS
TABLE 32. BECKMAN COULTER, INC.: PRODUCT PORTFOLIO
TABLE 33. BECKMAN COULTER, INC.: KEY STRATERGIES
TABLE 34. EKF DIAGNOSTICS: KEY EXECUTIVES
TABLE 35. EKF DIAGNOSTICS: COMPANY SNAPSHOT
TABLE 36. EKF DIAGNOSTICS: OPERATING SEGMENTS
TABLE 37. EKF DIAGNOSTICS: PRODUCT PORTFOLIO
TABLE 38. EKF DIAGNOSTICS: KEY STRATERGIES
TABLE 39. HDI DIAGNOSTICS: KEY EXECUTIVES
TABLE 40. HDI DIAGNOSTICS: COMPANY SNAPSHOT
TABLE 41. HDI DIAGNOSTICS: OPERATING SEGMENTS
TABLE 42. HDI DIAGNOSTICS: PRODUCT PORTFOLIO
TABLE 43. HDI DIAGNOSTICS: KEY STRATERGIES
TABLE 44. MENARINI DIAGNOSTICS: KEY EXECUTIVES
TABLE 45. MENARINI DIAGNOSTICS: COMPANY SNAPSHOT
TABLE 46. MENARINI DIAGNOSTICS: OPERATING SEGMENTS
TABLE 47. MENARINI DIAGNOSTICS: PRODUCT PORTFOLIO
TABLE 48. MENARINI DIAGNOSTICS: KEY STRATERGIES
TABLE 49. ARKRAY, INC.: KEY EXECUTIVES
TABLE 50. ARKRAY, INC.: COMPANY SNAPSHOT
TABLE 51. ARKRAY, INC.: OPERATING SEGMENTS
TABLE 52. ARKRAY, INC.: PRODUCT PORTFOLIO
TABLE 53. ARKRAY, INC.: KEY STRATERGIES
LIST OF FIGURES
FIGURE 01. ITALY POINT-OF-CARE GLUCOSE TESTING MARKET, 2022-2032
FIGURE 02. SEGMENTATION OF ITALY POINT-OF-CARE GLUCOSE TESTING MARKET, 2022-2032
FIGURE 03. TOP INVESTMENT POCKETS IN ITALY POINT-OF-CARE GLUCOSE TESTING MARKET (2023-2032)
FIGURE 04. PORTER FIVE-1
FIGURE 05. PORTER FIVE-2
FIGURE 06. PORTER FIVE-3
FIGURE 07. PORTER FIVE-4
FIGURE 08. PORTER FIVE-5
FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: ITALY POINT-OF-CARE GLUCOSE TESTING MARKET
FIGURE 10. ITALY POINT-OF-CARE GLUCOSE TESTING MARKET,BY PRODUCT TYPE, 2022 ($MILLION)
FIGURE 11. ITALY POINT-OF-CARE GLUCOSE TESTING MARKET,BY APPLICATION, 2022 ($MILLION)
FIGURE 12. ITALY POINT-OF-CARE GLUCOSE TESTING MARKET,BY END USER, 2022 ($MILLION)
FIGURE 13. TOP WINNING STRATEGIES, BY YEAR
FIGURE 14. TOP WINNING STRATEGIES, BY DEVELOPMENT
FIGURE 15. TOP WINNING STRATEGIES, BY COMPANY
FIGURE 16. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 17. COMPETITIVE DASHBOARD
FIGURE 18. COMPETITIVE HEATMAP: ITALY POINT-OF-CARE GLUCOSE TESTING MARKET
FIGURE 19. TOP PLAYER POSITIONING, 2022
FIGURE 20. ROCHE DIAGNOSTICS: NET SALES, 2020-2022*($MILLION)
FIGURE 21. ROCHE DIAGNOSTICS: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 22. ROCHE DIAGNOSTICS: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 23. ABBOTT LABORATORIES: NET SALES, 2020-2022*($MILLION)
FIGURE 24. ABBOTT LABORATORIES: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 25. ABBOTT LABORATORIES: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 26. BECTON, DICKINSON AND CO.: NET SALES, 2020-2022*($MILLION)
FIGURE 27. BECTON, DICKINSON AND CO.: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 28. BECTON, DICKINSON AND CO.: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 29. BAYER AG: NET SALES, 2020-2022*($MILLION)
FIGURE 30. BAYER AG: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 31. BAYER AG: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 32. NOVA BIOMEDICAL CORPORATION: NET SALES, 2020-2022*($MILLION)
FIGURE 33. NOVA BIOMEDICAL CORPORATION: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 34. NOVA BIOMEDICAL CORPORATION: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 35. BECKMAN COULTER, INC.: NET SALES, 2020-2022*($MILLION)
FIGURE 36. BECKMAN COULTER, INC.: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 37. BECKMAN COULTER, INC.: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 38. EKF DIAGNOSTICS: NET SALES, 2020-2022*($MILLION)
FIGURE 39. EKF DIAGNOSTICS: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 40. EKF DIAGNOSTICS: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 41. HDI DIAGNOSTICS: NET SALES, 2020-2022*($MILLION)
FIGURE 42. HDI DIAGNOSTICS: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 43. HDI DIAGNOSTICS: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 44. MENARINI DIAGNOSTICS: NET SALES, 2020-2022*($MILLION)
FIGURE 45. MENARINI DIAGNOSTICS: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 46. MENARINI DIAGNOSTICS: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 47. ARKRAY, INC.: NET SALES, 2020-2022*($MILLION)
FIGURE 48. ARKRAY, INC.: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 49. ARKRAY, INC.: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security